G.L. PHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5272946604

KRS0000877238

Share capital100,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. SIENNA 75, 00-833 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

G.L. PHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. SIENNA 75, 00-833 WARSZAWA

Show on map

NIP

5272946604

REGON

387922142

KRS

0000877238

Legal form

limited liability company

Register Address

UL. SIENNA 75, 00-833 WARSZAWA

Date of registration in KRS

2021-01-12

Date of commencement of economic activity

2021-01-12

Act signature

WA.XIII NS-REJ.KRS/29848/24/967/ADE

Pkd codes

73.11.Z - Advertising agency activities

46 - Wholesale trade

46.46.Z - Wholesale trade of pharmaceutical and medical products

47 - Retail trade

47.73.Z - Retail sale of pharmaceutical products

70.22.Z - Head office activities and management consultancy

73.20.Z - Market research and public opinion polling

74.90.Z - Other professional, scientific and technical activities, not elsewhere classified

82.99.Z - Other business support activities, not elsewhere classified

Payer VAT status

Active

Vat list bank account(s)

PL26 1240 1040 1111 0011 0317 7925

Company authorities

representation authorityMANAGEMENT

representation type

SPÓŁKĘ REPREZENTUJE KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE.

MANAGEMENT

Martin Bartenstein

Member Of The Board

Agata Franciszka Litwińska Mazur

Member Of The Board, 45 years old

shareholders

G.L. PHARMA GMBH (SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ)

100% 2000 udziałów o łącznej wartości 100.000,00 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2020	2021	2022
	M PLN	M PLN	M PLN	%
Assets	0	2,8	4,4	58
Gross profit (loss)	0	0,4	1,6	356
EBITDA	0	0,6	1,6	183,8
Net profit (loss)	0	-0,1	0,9	1654,6
Cash	0	0,4	1	165,2
Liabilities and provisions for liabilities	0	0,7	1,4	98,8
Net income from sale	0	17,7	26,8	51,2
Short time liabilities	0	0,3	0,6	131,8
Working assets	0	2,7	4,3	59,1
Equity capital	0	2	2,9	43,6
Operating profit (EBIT)	0	0,4	1,6	356
Depreciation	0	0,2	0	-79,8
	%	%	%	p.p.
Profitability of capital		-2,8	30,4	33,2
Equity capital to total assets		73,8	67,1	-6,7
Gross profit margin		2	6	4
EBITDA Margin		3,3	6,2	2,9
	Days	Days	Days	Days
Short term commitment turnover cycle	0	6	9	3